Szetalo Plus 5 Tablet

Szetalo Plus 5 Tablet contains a combination of Clonazepam and Escitalopram Oxalate used to treat Anxiety Disorders. Clonazepam belongs to the benzodiazepine class and works by boosting the effects of a substance in the brain called gamma-aminobutyric acid (GABA). This helps reduce unusual nerve activity. Escitalopram Oxalate, an SSRI (Selective Serotonin Reuptake Inhibitor), enhances serotonin levels in the brain, improving mood and behavior. Together, they help relieve conditions associated with excessive nerve activity and contribute to an overall enhancement in emotional well-being.

Clonazepam enhances the effects of GABA, which calms the nerves and reduces abnormal nerve signals. Escitalopram Oxalate increases serotonin levels, which helps improve mood and behavior. When used together, they collaborate to alleviate excessive nerve activity, promoting emotional well-being.

Follow your doctor's advice on how to take this medicine. It can be taken with or without food, but it's best to take it at the same time daily for better outcomes.

Possible side effects may include depression, dizziness, drowsiness, fatigue, impaired coordination, and memory impairment.

It can cause central nervous system depression, leading to drowsiness and sedation. Be cautious when operating machinery, driving, or doing activities that require alertness until you know how this combination affects you.

Clonazepam, being a benzodiazepine, may lead to tolerance and physical dependence with prolonged use. Abruptly stopping Clonazepam can cause withdrawal symptoms, including seizures. Always use Clonazepam under medical supervision and as prescribed.

If you miss a dose, take it as soon as you remember. However, if the next dose is near, skip the missed one and stick to your regular schedule. Avoid taking double doses. It's advisable to consult your doctor on managing missed doses effectively.

Always adhere to your doctor's guidance and discuss any concerns or difficulties you experience while taking this medicine.